- Home
- PULM vs ZBAO Comparison
PULM vs ZBAO Comparison
Compare PULM & ZBAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- ZBAO
- Stock Information
- Founded
- PULM 2003
- ZBAO 2015
- Country
- PULM United States
- ZBAO China
- Employees
- PULM N/A
- ZBAO N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- ZBAO
- Sector
- PULM Health Care
- ZBAO
- Exchange
- PULM Nasdaq
- ZBAO NYSE
- Market Cap
- PULM 33.2M
- ZBAO 34.5M
- IPO Year
- PULM N/A
- ZBAO 2024
- Fundamental
- Price
- PULM $6.53
- ZBAO $0.96
- Analyst Decision
- PULM
- ZBAO
- Analyst Count
- PULM 0
- ZBAO 0
- Target Price
- PULM N/A
- ZBAO N/A
- AVG Volume (30 Days)
- PULM 63.0K
- ZBAO 128.9K
- Earning Date
- PULM 08-12-2025
- ZBAO 04-15-2025
- Dividend Yield
- PULM N/A
- ZBAO N/A
- EPS Growth
- PULM N/A
- ZBAO N/A
- EPS
- PULM N/A
- ZBAO 0.09
- Revenue
- PULM $1,921,000.00
- ZBAO $33,673,520.00
- Revenue This Year
- PULM N/A
- ZBAO $65.08
- Revenue Next Year
- PULM $134.88
- ZBAO $34.27
- P/E Ratio
- PULM N/A
- ZBAO $10.66
- Revenue Growth
- PULM N/A
- ZBAO 82.66
- 52 Week Low
- PULM $1.78
- ZBAO $0.78
- 52 Week High
- PULM $10.40
- ZBAO $4.27
- Technical
- Relative Strength Index (RSI)
- PULM 41.09
- ZBAO N/A
- Support Level
- PULM $6.51
- ZBAO N/A
- Resistance Level
- PULM $7.00
- ZBAO N/A
- Average True Range (ATR)
- PULM 0.89
- ZBAO 0.00
- MACD
- PULM -0.16
- ZBAO 0.00
- Stochastic Oscillator
- PULM 44.16
- ZBAO 0.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About ZBAO ZHIBAO TECHNOLOGY INC
Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.